Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
3.085
+0.505 (19.56%)
Jan 23, 2025, 12:35 PM EST - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $420.95 million as of January 23, 2025. Its market cap has increased by 113.08% in one year.
Market Cap
420.95M
Enterprise Value
266.36M
1-Year Change
113.08%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $420.95M, a decrease of -3.30%. That is a compound annual growth rate of -0.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 359.11M | 80.00% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.64B |
| UnitedHealth Group | 477.92B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 349.71B |
| AbbVie | 298.91B |
| Merck & Co. | 242.01B |
| Thermo Fisher Scientific | 219.73B |
| Intuitive Surgical | 217.43B |